nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer
|
Li, Lan Ying |
|
|
29 |
2 |
p. 334-340 |
artikel |
2 |
A novel prediction method for lymph node involvement in endometrial cancer: machine learning
|
Günakan, Emre |
|
|
29 |
2 |
p. 320-324 |
artikel |
3 |
Are omentectomy and lymphadenectomy necessary in patients with apparently early-stage malignant ovarian germ cell tumors?
|
Qin, Beijiao |
|
|
29 |
2 |
p. 398-403 |
artikel |
4 |
A report on the Marrakech International Women’s Cancer Days: dialogs and implications
|
Nasser, Sara |
|
|
29 |
2 |
p. 417-421 |
artikel |
5 |
Association of human papillomavirus and bacterial vaginosis with increased risk of high-grade squamous intraepithelial cervical lesions
|
Suehiro, Tamy Tiemi |
|
|
29 |
2 |
p. 242-249 |
artikel |
6 |
Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study
|
Maltese, Giuseppa |
|
|
29 |
2 |
p. 272-276 |
artikel |
7 |
Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study
|
Lago, V |
|
|
29 |
2 |
p. 377-381 |
artikel |
8 |
Conservative management of cervical cancer in pregnancy
|
Ramirez, Pedro T |
|
|
29 |
2 |
p. 434-438 |
artikel |
9 |
DNA ploidy status, S-phase fraction, and p53 are not independent prognostic factors for survival in endometrioid endometrial carcinoma FIGO stage I–III
|
Svanvik, Teresia |
|
|
29 |
2 |
p. 305-311 |
artikel |
10 |
Does lymphadenectomy improve survival in patients with intermediate risk endometrial cancer? A multicentric study from the FRANCOGYN Research Group
|
Bougherara, Lilia |
|
|
29 |
2 |
p. 282-289 |
artikel |
11 |
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer
|
Morgan, Robert D |
|
|
29 |
2 |
p. 341-345 |
artikel |
12 |
Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer
|
Horeweg, Nanda |
|
|
29 |
2 |
p. 257-265 |
artikel |
13 |
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer
|
Veneris, Jennifer Taylor |
|
|
29 |
2 |
p. 357-364 |
artikel |
14 |
Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results
|
Böhm, Steffen |
|
|
29 |
2 |
p. 353-356 |
artikel |
15 |
How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers
|
Vésale, Elie |
|
|
29 |
2 |
p. 443 |
artikel |
16 |
Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma
|
Osakabe, Mitsumasa |
|
|
29 |
2 |
p. 277-281 |
artikel |
17 |
Improving the quality of care in a public hospital in Guatemala
|
Estrada, Erick Estuardo |
|
|
29 |
2 |
p. 439-440 |
artikel |
18 |
Inguino-abdominal combined approach for laterally extended pelvic resection: a step by step procedure
|
Vizzielli, Giuseppe |
|
|
29 |
2 |
p. 443-444 |
artikel |
19 |
Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer
|
Timmermans, Maite |
|
|
29 |
2 |
p. 392-397 |
artikel |
20 |
Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience
|
Volpi, Lavinia |
|
|
29 |
2 |
p. 312-319 |
artikel |
21 |
Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article
|
Maggen, Charlotte |
|
|
29 |
2 |
p. 404-416 |
artikel |
22 |
Patterns of care and outcomes for women with uterine cancer and ovarian metastases
|
Jones, Nathaniel L |
|
|
29 |
2 |
p. 365-376 |
artikel |
23 |
Persuasive messaging for human papillomavirus vaccination by adolescent providers in a five-country multi-site study
|
Rwamwejo, Janvier |
|
|
29 |
2 |
p. 250-256 |
artikel |
24 |
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
|
Rivkin, Saul Eugene |
|
|
29 |
2 |
p. 325-333 |
artikel |
25 |
Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis
|
Angeles, Martina Aida |
|
|
29 |
2 |
p. 382-391 |
artikel |
26 |
Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography
|
Alcázar, Juan Luis |
|
|
29 |
2 |
p. 227-233 |
artikel |
27 |
Pre-operative evaluation in advanced ovarian cancer: is ultrasound ready to replace computed tomography?
|
Verri, Debora |
|
|
29 |
2 |
p. 225-226 |
artikel |
28 |
Reviewing vulvar Paget’s disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE
|
Mantovani, Giulia |
|
|
29 |
2 |
p. 422-429 |
artikel |
29 |
Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology–HPV cotesting and follow-up biopsies
|
Ge, Yimin |
|
|
29 |
2 |
p. 234-241 |
artikel |
30 |
The anatomical structure of the paravesico-vaginal space, a novel landmark for nerve-sparing radical hysterectomy
|
Yin, Sheng |
|
|
29 |
2 |
p. 441 |
artikel |
31 |
The association between histological subtype of a first primary endometrial cancer and second cancer risk
|
Rhoades, Jennifer |
|
|
29 |
2 |
p. 290-298 |
artikel |
32 |
The role of positron emission tomography in the selection of patients for salvage hysterectomy following chemoradiotherapy for locally advanced cervical cancer
|
Rajasooriyar, Chrishanthi |
|
|
29 |
2 |
p. 266-271 |
artikel |
33 |
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
|
Mandilaras, Victoria |
|
|
29 |
2 |
p. 346-352 |
artikel |
34 |
Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
|
Moore, Kathleen N |
|
|
29 |
2 |
p. 430-433 |
artikel |
35 |
Vaginal hysterectomy with or without bilateral salpingo-oophorectomy may be an alternative treatment for endometrial cancer patients with medical co-morbidities precluding standard surgical procedures: a systematic review
|
Kruse, Arnold-Jan |
|
|
29 |
2 |
p. 299-304 |
artikel |